Showing 521 - 540 results of 681 for search '(( 6 10 decrease ) OR ( 10 (((peer OR per) decrease) OR (((nn decrease) OR (mean decrease)))) ))*', query time: 0.15s Refine Results
  1. 521
  2. 522

    A 5-year trend in the use of sodium-glucose co-transporter 2 inhibitors and other oral antidiabetic drugs in a Middle Eastern country by Zaghloul, Nancy

    Published 2022
    “…Among SGLT2is, empagliflozin prescriptions showed an increase from 537 (10.65%) to 2881 (34.40%) compared to dapagliflozin, which decreased by the end of 2018 from 4505 (89.35%) to 5494 (65.6%). …”
    Get full text
    Get full text
  3. 523
  4. 524
  5. 525
  6. 526
  7. 527
  8. 528
  9. 529
  10. 530
  11. 531
  12. 532
  13. 533
  14. 534
  15. 535
  16. 536

    Omega-3 fatty acid-rich fish oil supplementation prevents rosiglitazone-induced osteopenia in aging mice by Cugno, Chiara

    Published 2021
    “…Rosiglitazone is an effective insulin-sensitizer, however, associated with bone loss mainly due to increased bone resorption, and bone marrow adiposity, and decreased bone formation. We investigated the effect of the co-administration of fish oil (FO) rich in omega-3 fatty acids (FAs) on rosiglitazone (RSG)-induced bone loss in aging C57BL/6 mice and the mechanisms underlying potential preventive effect. …”
    Get full text
    Get full text
  17. 537
  18. 538
  19. 539
  20. 540